| 研究报告 |
|
|
|
|
| CHD5基因RNAi慢病毒载体的构建及其对结直肠癌细胞生物学功能的影响 |
| 赵蕊, 吕静野, 黄海丽, 严启滔 |
| 南方医科大学基因工程研究所 广州 501515 |
|
| Construction of Recombinant Lentiviral Vector of shRNA for CHD5 Gene and the Study of Its Functions in Human Colon Carcinoma Lovo Cells |
| ZHAO Rui, LV Jing-ye, HUANG Hai-li, YAN Qi-tao |
| Institute of Genetic Engineering of Southern Medical University, Guangzhou 510515, China |
引用本文:
赵蕊, 吕静野, 黄海丽, 严启滔. CHD5基因RNAi慢病毒载体的构建及其对结直肠癌细胞生物学功能的影响[J]. 中国生物工程杂志, 2012, 32(05): 7-11.
ZHAO Rui, LV Jing-ye, HUANG Hai-li, YAN Qi-tao. Construction of Recombinant Lentiviral Vector of shRNA for CHD5 Gene and the Study of Its Functions in Human Colon Carcinoma Lovo Cells. China Biotechnology, 2012, 32(05): 7-11.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I05/7
|
|
[1] Brodeur G M, Maris J M, Yamashiro D J, et al. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol, 1997,19(2):93-101.
[2] Hogarty M D, Liu X, Guo C, et al. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med Pediatr Oncol,2000, 35(6):512-515.
[3] Maris J M, Guo C, Blake D, et al. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol,2001, 36(1):32-36.
[4] White P S, Maris J M, Sulman E P, et al. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. Eur J Cancer, 1997,33(2):1957-1961.
[5] Bagchi A, Papazoglu C, Wu Y,et al. CHD5 is a tumor suppressor at human 1p36. Cell, 2007,128(3): 459-475.
[6] Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells. Med Sci Monit, 2002, 8 (12):521-526.
[7] Morris K V, Rossi J J. Lentiviral mediated delivery of siRNAs for antiviral therapy. Gene Ther, 2006, 13 (6):553-558.
[8] Kock N, Kasmieh R, Weissleder R,et al. Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL. Neoplasia, 2007, 9 (5):435-442.
[9] Cockrell A S, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol, 2007, 36 (3):184-204.
[10] Sumimoto H, Kawakami Y. Lentiviral vector mediated RNAi and its use for cancer research. Future Oncol, 2007, 3 (6):655-664.
[11] Zeng Y. Principles of micro-RNA production and maturation. Oncogene, 2006, 25 (46):6156-6162.
[12] Brodeur G M, Sekhon G, Goldstein M N. Chromosomal aberrations in human neuroblastomas. Cancer,1977,40(5):2256-2263.
[13] White P S, Thompson P M, Gotoh T,et al. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene,2005, 24(16): 2684-2694.
[14] Piaskowski S, Rieske P, Szybka M,et al. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet. Cytogenet.,2005, 162(1): 63-67.
[15] Poetsch M, Dittberner T, Woenckhaus C. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region. Melanoma Res, 2003,13(1): 29-33.
[16] Moley J F, Brother M B, Fong C T,et al. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res,1992,52(4): 770-774.
[17] Bello M J, Leone P E, Vaquero J,et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer,1995,64(3):207-210.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
